3101 - 3150 of 8399 Results
Title
Year
- Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study2021OPENTitle: Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 9Start Page: 739End Page: 752Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00214-3Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711249Citation Count: 382
-
OPENTitle: “Real‐Life” Remote Dystonia Assessment: Feasibility, Accuracy, and Practice ImplicationsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 8Start Page: 1269End Page: 1271Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13330Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13330Citation Count: 2
-
OPENTitle: Apathy: An underestimated feature in GBA and LRRK2 non-manifesting mutation carriersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 91Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.08.008Best OA location URL: https://www.medrxiv.org/content/medrxiv/early/2021/07/22/2021.07.20.21260819.full.pdfCitation Count: 10
- Multitarget Transcranial Electrical Stimulation for Freezing of Gait: A Randomized Controlled Trial2021RESTRICTEDTitle: Multitarget Transcranial Electrical Stimulation for Freezing of Gait: A Randomized Controlled TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2693End Page: 2698Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28759Citation Count: 25
- Polyglutamine‐Expanded Ataxin‐3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral Blood2021OPENTitle: Polyglutamine‐Expanded Ataxin‐3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral BloodJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2675End Page: 2681Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.28749Best OA location URL: https://pure.rug.nl/ws/files/201831796/Movement_Disorders_2021_H_bener_Schmid_Polyglutamine_Expanded_Ataxin_3_A_Target_Engagement_Marker_for.pdfCitation Count: 28
-
RESTRICTEDTitle: Estimating the Risk of Deep Brain Stimulation in the Modern Era: 2008 to 2020Journal Name: Operative NeurosurgeryPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 5Start Page: 277End Page: 290Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/ons/opab261Citation Count: 15
- Basal Synaptic Transmission and Long-Term Plasticity at CA3-CA1 Synapses Are Unaffected in Young Adult PINK1-Deficient Rats2021OPENTitle: Basal Synaptic Transmission and Long-Term Plasticity at CA3-CA1 Synapses Are Unaffected in Young Adult PINK1-Deficient RatsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.655901Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2021.655901/pdfCitation Count: 2
- Duration and onset of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naïve subjects2021OPENTitle: Duration and onset of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naïve subjectsJournal Name: Current Medical Research and OpinionPublisher: Informa UK LimitedVol: 37Issue #: 10Start Page: 1761End Page: 1768Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/03007995.2021.1965975Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/03007995.2021.1965975?needAccess=trueCitation Count: 8
- Developing methods to detect and diagnose chronic traumatic encephalopathy during life: rationale, design, and methodology for the DIAGNOSE CTE Research Project2021OPENTitle: Developing methods to detect and diagnose chronic traumatic encephalopathy during life: rationale, design, and methodology for the DIAGNOSE CTE Research ProjectJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-021-00872-xBest OA location URL: https://alzres.biomedcentral.com/counter/pdf/10.1186/s13195-021-00872-xCitation Count: 57
- Genetic association of primary nonresponse to anti-TNFα therapy in patients with inflammatory bowel disease2021OPENTitle: Genetic association of primary nonresponse to anti-TNFα therapy in patients with inflammatory bowel diseaseJournal Name: Pharmacogenetics and GenomicsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 32Issue #: 1Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/fpc.0000000000000445Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578201Citation Count: 3
- Restriction of Access to Deep Brain Stimulation for Refractory OCD: Failure to Apply the Federal Parity Act2021OPENTitle: Restriction of Access to Deep Brain Stimulation for Refractory OCD: Failure to Apply the Federal Parity ActJournal Name: Frontiers in PsychiatryPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fpsyt.2021.706181Best OA location URL: https://www.frontiersin.org/articles/10.3389/fpsyt.2021.706181/pdfCitation Count: 17
-
OPENTitle: Humanized Biomimetic Nanovesicles for Neuron TargetingJournal Name: Advanced SciencePublisher: WileyVol: 8Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/advs.202101437Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/advs.202101437Citation Count: 26
-
OPENTitle: The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular modelJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-25060-1Best OA location URL: https://www.nature.com/articles/s41467-021-25060-1.pdfCitation Count: 51
-
OPENTitle: Dying-back of ascending noradrenergic projections in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 9Start Page: 2562End Page: 2564Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awab286Best OA location URL: https://academic.oup.com/brain/article-pdf/144/9/2562/40880422/awab286.pdfCitation Count: 5
-
OPENTitle: Miro1 Impairment in a Parkinson’s At-Risk CohortJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2021.734273Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2021.734273/pdfCitation Count: 12
-
OPENTitle: Remote smartphone monitoring of Parkinson’s disease and individual response to therapyJournal Name: Nature BiotechnologyPublisher: Springer Science and Business Media LLCVol: 40Issue #: 4Start Page: 480End Page: 487Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41587-021-00974-9Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/252104/252104.pdfCitation Count: 115
-
OPENTitle: Does the Anti‐Tau Strategy in Progressive Supranuclear Palsy Need to Be Reconsidered? YesJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 7Start Page: 1034End Page: 1037Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13324Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13324Citation Count: 2
-
RESTRICTEDTitle: On‐Demand Therapy for OFF Episodes in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2244End Page: 2253Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28726Citation Count: 18
-
OPENTitle: Systematic Assessment of 10 Biomarker Candidates Focusing on α‐Synuclein‐Related DisordersJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2874End Page: 2887Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28738Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28738Citation Count: 82
- Longitudinal tracking of neuronal mitochondria delineates PINK1/Parkin-dependent mechanisms of mitochondrial recycling and degradation2021OPENTitle: Longitudinal tracking of neuronal mitochondria delineates PINK1/Parkin-dependent mechanisms of mitochondrial recycling and degradationJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 7Issue #: 32Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.abf6580Best OA location URL: https://escholarship.org/content/qt0pp8k1kx/qt0pp8k1kx.pdf?t=qya4liCitation Count: 28
- Metabolic Profiling of Neocortical Tissue Discriminates Alzheimer’s Disease from Mild Cognitive Impairment, High Pathology Controls, and Normal Controls2021OPENTitle: Metabolic Profiling of Neocortical Tissue Discriminates Alzheimer’s Disease from Mild Cognitive Impairment, High Pathology Controls, and Normal ControlsJournal Name: Journal of Proteome ResearchPublisher: American Chemical Society (ACS)Vol: 20Issue #: 9Start Page: 4303End Page: 4317Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jproteome.1c00290Best OA location URL: https://www.researchsquare.com/article/rs-110947/latest.pdfCitation Count: 39
- Structural network topology and microstructural alterations of the anterior insula associate with cognitive and affective impairment in Parkinson’s disease2021OPENTitle: Structural network topology and microstructural alterations of the anterior insula associate with cognitive and affective impairment in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-95638-8Best OA location URL: https://www.nature.com/articles/s41598-021-95638-8.pdfCitation Count: 15
- Whole brain and deep gray matter structure segmentation: Quantitative comparison between MPRAGE and MP2RAGE sequences2021OPENTitle: Whole brain and deep gray matter structure segmentation: Quantitative comparison between MPRAGE and MP2RAGE sequencesJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 8Start Page: e0254597End Page: e0254597Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0254597Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0254597&type=printableCitation Count: 10
-
OPENTitle: C9orf72-G4C2 Intermediate Repeats and Parkinson’s Disease; A Data-Driven HypothesisJournal Name: GenesPublisher: MDPI AGVol: 12Issue #: 8Start Page: 1210End Page: 1210Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes12081210Best OA location URL: https://www.mdpi.com/2073-4425/12/8/1210/pdf?version=1628215581Citation Count: 3
- Fast 3D Clear: A Fast, Aqueous, Reversible Three-Day Tissue Clearing Method for Adult and Embryonic Mouse Brain and Whole Body2021RESTRICTEDTitle: Fast 3D Clear: A Fast, Aqueous, Reversible Three-Day Tissue Clearing Method for Adult and Embryonic Mouse Brain and Whole BodyJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.17632/jfcxnntcp5.2Citation Count: 0
-
OPENTitle: Predicting correlated outcomes from molecular dataJournal Name: BioinformaticsPublisher: Oxford University Press (OUP)Vol: 37Issue #: 21Start Page: 3889End Page: 3895Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/bioinformatics/btab576Best OA location URL: https://academic.oup.com/bioinformatics/article-pdf/37/21/3889/41091787/btab576.pdfCitation Count: 10
-
OPENTitle: Predictors of cognitive impairment in primary age-related tauopathy: an autopsy studyJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-021-01233-3Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-021-01233-3Citation Count: 54
- RNA sequencing of whole blood reveals early alterations in immune cells and gene expression in Parkinson’s disease2021RESTRICTEDTitle: RNA sequencing of whole blood reveals early alterations in immune cells and gene expression in Parkinson’s diseaseJournal Name: Nature AgingPublisher: Springer Science and Business Media LLCVol: 1Issue #: 8Start Page: 734End Page: 747Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s43587-021-00088-6Citation Count: 52
- A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic „CERAD-Plus“ tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE study2021RESTRICTEDTitle: A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic „CERAD-Plus“ tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 90Issue #:Start Page: 90End Page: 97Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.034Citation Count: 9
-
OPENTitle: Clinical and Genetic Analysis of Costa Rican Patients With Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3389/fneur.2021.656342Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.656342/pdfCitation Count: 6
- Generative image transformer (GIT): unsupervised continuous image generative and transformable model for [123I]FP-CIT SPECT images2021RESTRICTEDTitle: Generative image transformer (GIT): unsupervised continuous image generative and transformable model for [123I]FP-CIT SPECT imagesJournal Name: Annals of Nuclear MedicinePublisher: Springer Science and Business Media LLCVol: 35Issue #: 11Start Page: 1203End Page: 1213Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12149-021-01661-0Best OA location URL: https://repository.kulib.kyoto-u.ac.jp/dspace/bitstream/2433/275147/1/dnikk00096.pdfCitation Count: 12
- Native Separation and Metallation Analysis of SOD1 Protein from the Human Central Nervous System: a Methodological Workflow2021OPENTitle: Native Separation and Metallation Analysis of SOD1 Protein from the Human Central Nervous System: a Methodological WorkflowJournal Name: Analytical ChemistryPublisher: American Chemical Society (ACS)Vol: 93Issue #: 32Start Page: 11108End Page: 11115Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acs.analchem.1c01128Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.analchem.1c01128Citation Count: 7
- Pharmacological rescue of impaired mitophagy in Parkinson’s disease-related LRRK2 G2019S knock-in mice2021OPENTitle: Pharmacological rescue of impaired mitophagy in Parkinson’s disease-related LRRK2 G2019S knock-in miceJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.67604Best OA location URL: https://doi.org/10.7554/elife.67604Citation Count: 72
- Sex differences in brain atrophy and cognitive impairment in Parkinson’s disease patients with and without probable rapid eye movement sleep behavior disorder2021OPENTitle: Sex differences in brain atrophy and cognitive impairment in Parkinson’s disease patients with and without probable rapid eye movement sleep behavior disorderJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 3Start Page: 1591End Page: 1599Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-021-10728-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-021-10728-x.pdfCitation Count: 30
- Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disorders2021OPENTitle: Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disordersJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 93Issue #: 1Start Page: 24End Page: 31Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2021-326904Best OA location URL: https://hal.sorbonne-universite.fr/hal-03471111/documentCitation Count: 80
-
OPENTitle: Assessing the Quality and Reliability of COVID-19 Information on Patient Organization WebsitesJournal Name: Frontiers in CommunicationPublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcomm.2021.716683Best OA location URL: https://www.frontiersin.org/articles/10.3389/fcomm.2021.716683/pdfCitation Count: 8
- Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic Efficacy2021RESTRICTEDTitle: Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic EfficacyJournal Name:Publisher:Vol:Issue #:Start Page: 1306End Page: 1321Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acsptsci.0c00162;Citation Count: 9
- Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic Efficacy2021OPENTitle: Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic EfficacyJournal Name: ACS Pharmacology & Translational SciencePublisher: American Chemical Society (ACS)Vol: 4Issue #: 4Start Page: 1306End Page: 1321Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsptsci.0c00162Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369681Citation Count: 20
- Disentangling the PIGD classification for the prediction of cognitive impairment in de novo Parkinson’s disease2021OPENTitle: Disentangling the PIGD classification for the prediction of cognitive impairment in de novo Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 3Start Page: 1566End Page: 1573Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-021-10730-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-021-10730-3.pdfCitation Count: 10
-
OPENTitle: Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum ExposureJournal Name: Advanced SciencePublisher: WileyVol: 8Issue #: 18Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/advs.202101462Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/advs.202101462Citation Count: 127
-
RESTRICTEDTitle: Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2021 UpdateJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 11Issue #: 3Start Page: 891End Page: 903Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-219006Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd219006?id=journal-of-parkinsons-disease%2Fjpd219006Citation Count: 47
-
OPENTitle: Quality Improvement in NeurologyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 97Issue #: 5Start Page: 239End Page: 245Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000012198Best OA location URL: https://n.neurology.org/content/neurology/97/5/239.full.pdfCitation Count: 17
-
OPENTitle: A pipeline for RNA-seq based eQTL analysis with automated quality control proceduresJournal Name: BMC BioinformaticsPublisher: Springer Science and Business Media LLCVol: 22Issue #: S9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12859-021-04307-0Best OA location URL: https://bmcbioinformatics.biomedcentral.com/track/pdf/10.1186/s12859-021-04307-0Citation Count: 38
- Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder2021RESTRICTEDTitle: Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorderJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 8Start Page: 671End Page: 684Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00176-9Best OA location URL: https://pure.rug.nl/ws/files/200722774/PIIS1474442221001769.pdfCitation Count: 121
-
OPENTitle: Commentary: A Boy with Spells of Unusual Movements after Failure in ExamJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13291Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13291Citation Count: 0
- Commentary: Atypical, Early‐Onset Dystonia‐Parkinsonism with Oculogyric Crises and Anterior Horn Cell Disorder due to a Novel DJ ‐1 Mutation2021RESTRICTEDTitle: Commentary: Atypical, Early‐Onset Dystonia‐Parkinsonism with Oculogyric Crises and Anterior Horn Cell Disorder due to a Novel DJ ‐1 MutationJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13296;Citation Count: 1
- Commentary: Atypical, Early‐Onset Dystonia‐Parkinsonism with Oculogyric Crises and Anterior Horn Cell Disorder due to a Novel DJ ‐1 Mutation2021OPENTitle: Commentary: Atypical, Early‐Onset Dystonia‐Parkinsonism with Oculogyric Crises and Anterior Horn Cell Disorder due to a Novel DJ ‐1 MutationJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13296Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13296Citation Count: 3
-
OPENTitle: Commentary: Monochorea of the Upper Limb in a Patient with Spinocerebellar Ataxia Type 12Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13290Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13290Citation Count: 1
- Commentary: Paraneoplastic Syndrome Associated with Kelch‐Like Protein 11 Antibodies Presenting with Progressive Ataxia and Tremor2021OPENTitle: Commentary: Paraneoplastic Syndrome Associated with Kelch‐Like Protein 11 Antibodies Presenting with Progressive Ataxia and TremorJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13300Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13300Citation Count: 3
-
OPENTitle: Commentary: Uremic Striatopallidal Syndrome Manifesting as Acute Onset ChoreaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13299Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13299Citation Count: 0